Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Chlamydia pneumoniae: An Etiologic Agent for Late-Onset Dementia.

Balin BJ, Hammond CJ, Little CS, Hingley ST, Al-Atrache Z, Appelt DM, Whittum-Hudson JA, Hudson AP.

Front Aging Neurosci. 2018 Oct 9;10:302. doi: 10.3389/fnagi.2018.00302. eCollection 2018. Review.

2.

Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection.

Ganda IS, Zhong Q, Hali M, Albuquerque RLC, Padilha FF, da Rocha SRP, Whittum-Hudson JA.

Int J Pharm. 2017 Jul 15;527(1-2):79-91. doi: 10.1016/j.ijpharm.2017.05.045. Epub 2017 May 22.

3.

Microbes and Alzheimer's Disease.

Itzhaki RF, Lathe R, Balin BJ, Ball MJ, Bearer EL, Braak H, Bullido MJ, Carter C, Clerici M, Cosby SL, Del Tredici K, Field H, Fulop T, Grassi C, Griffin WS, Haas J, Hudson AP, Kamer AR, Kell DB, Licastro F, Letenneur L, Lövheim H, Mancuso R, Miklossy J, Otth C, Palamara AT, Perry G, Preston C, Pretorius E, Strandberg T, Tabet N, Taylor-Robinson SD, Whittum-Hudson JA.

J Alzheimers Dis. 2016;51(4):979-84. doi: 10.3233/JAD-160152. Review. No abstract available.

4.

Folate-functionalized dendrimers for targeting Chlamydia-infected tissues in a mouse model of reactive arthritis.

Benchaala I, Mishra MK, Wykes SM, Hali M, Kannan RM, Whittum-Hudson JA.

Int J Pharm. 2014 May 15;466(1-2):258-65. doi: 10.1016/j.ijpharm.2014.03.018. Epub 2014 Mar 5.

PMID:
24607214
5.

Dendrimer-enabled transformation of Chlamydia trachomatis.

Kannan RM, Gérard HC, Mishra MK, Mao G, Wang S, Hali M, Whittum-Hudson JA, Hudson AP.

Microb Pathog. 2013 Dec;65:29-35. doi: 10.1016/j.micpath.2013.08.003. Epub 2013 Sep 25.

PMID:
24075820
6.

Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae.

Gérard HC, Mishra MK, Mao G, Wang S, Hali M, Whittum-Hudson JA, Kannan RM, Hudson AP.

Nanomedicine. 2013 Oct;9(7):996-1008. doi: 10.1016/j.nano.2013.04.004. Epub 2013 Apr 29.

PMID:
23639679
7.

The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.

Carter JD, Gerard HC, Whittum-Hudson JA, Hudson AP.

Int J Clin Rheumtol. 2012 Dec 1;7(6):627-640.

8.

Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis.

Mishra MK, Gérard HC, Whittum-Hudson JA, Hudson AP, Kannan RM.

Mol Pharm. 2012 Mar 5;9(3):413-21. doi: 10.1021/mp200512f. Epub 2012 Jan 30.

PMID:
22263556
9.

Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?

Carter JD, Gérard HC, Whittum-Hudson JA, Hudson AP.

Int J Clin Rheumtol. 2011 Jun;6(3):333-345.

10.

PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections.

Mishra MK, Kotta K, Hali M, Wykes S, Gerard HC, Hudson AP, Whittum-Hudson JA, Kannan RM.

Nanomedicine. 2011 Dec;7(6):935-44. doi: 10.1016/j.nano.2011.04.008. Epub 2011 May 19.

PMID:
21658474
11.

Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles.

Toti US, Guru BR, Hali M, McPharlin CM, Wykes SM, Panyam J, Whittum-Hudson JA.

Biomaterials. 2011 Sep;32(27):6606-13. doi: 10.1016/j.biomaterials.2011.05.038. Epub 2011 Jun 8.

12.

Functional CCR5 receptor protects patients with arthritis from high synovial burden of infecting Chlamydia trachomatis.

Gérard HC, Stanich JA, Oszust CE, Whittum-Hudson JA, Carter JD, Schumacher HR, Hudson AP.

Am J Med Sci. 2010 Dec;340(6):448-51. doi: 10.1097/MAJ.0b013e3181ee6a62.

13.

The potential for the noninvasive delivery of polymeric nanocarriers using propellant-based inhalers in the treatment of Chlamydial respiratory infections.

Bharatwaj B, Wu L, Whittum-Hudson JA, da Rocha SR.

Biomaterials. 2010 Oct;31(28):7376-85. doi: 10.1016/j.biomaterials.2010.06.005.

PMID:
20615546
14.

Protective immunity to chlamydial genital infection: evidence from animal studies.

Rank RG, Whittum-Hudson JA.

J Infect Dis. 2010 Jun 15;201 Suppl 2:S168-77. doi: 10.1086/652399. Review.

PMID:
20470052
15.

The pathogenic role of Chlamydia in spondyloarthritis.

Gérard HC, Whittum-Hudson JA, Carter JD, Hudson AP.

Curr Opin Rheumatol. 2010 Jul;22(4):363-7. doi: 10.1097/BOR.0b013e32833952cb. Review.

PMID:
20414116
16.

Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue.

Gerard HC, Stanich JA, Whittum-Hudson JA, Schumacher HR, Carter JD, Hudson AP.

Microb Pathog. 2010 Feb;48(2):62-8. doi: 10.1016/j.micpath.2009.11.004. Epub 2009 Nov 18.

17.

Kinematics of intracellular chlamydiae provide evidence for contact-dependent development.

Wilson DP, Whittum-Hudson JA, Timms P, Bavoil PM.

J Bacteriol. 2009 Sep;191(18):5734-42. doi: 10.1128/JB.00293-09. Epub 2009 Jun 19.

18.

Molecular biology of infectious agents in chronic arthritis.

Gérard HC, Whittum-Hudson JA, Carter JD, Hudson AP.

Rheum Dis Clin North Am. 2009 Feb;35(1):1-19. doi: 10.1016/j.rdc.2009.03.011. Review.

PMID:
19480994
19.

Lack of evidence for bacterial infections in skin in patients with systemic sclerosis.

Mayes MD, Whittum-Hudson JA, Oszust C, Gérard HC, Hudson AP.

Am J Med Sci. 2009 Apr;337(4):233-5.

20.

Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain.

Dreses-Werringloer U, Bhuiyan M, Zhao Y, Gérard HC, Whittum-Hudson JA, Hudson AP.

Int J Med Microbiol. 2009 Mar;299(3):187-201. doi: 10.1016/j.ijmm.2008.07.002. Epub 2008 Sep 30.

21.

Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease.

Balin BJ, Little CS, Hammond CJ, Appelt DM, Whittum-Hudson JA, Gérard HC, Hudson AP.

J Alzheimers Dis. 2008 May;13(4):371-80. Review.

PMID:
18487846
22.

Analysis of estrogen binding sites of the posterior ligament of the human TMJ.

Henry CH, Tull GT, Whittum-Hudson JA, Wolford LM.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jun;105(6):698-701. doi: 10.1016/j.tripleo.2007.08.028. Epub 2008 Mar 4.

PMID:
18299228
23.

Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice.

Jabs DA, Prendergast RA, Campbell AL, Lee B, Akpek EK, Gérard HC, Hudson AP, Whittum-Hudson JA.

Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5624-9.

24.

Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells.

Gérard HC, Fomicheva E, Whittum-Hudson JA, Hudson AP.

Microb Pathog. 2008 Apr;44(4):279-85. Epub 2007 Oct 18.

PMID:
17997273
25.

Reactive arthritis and internal derangement of the temporomandibular joint.

Henry CH, Whittum-Hudson JA, Tull GT, Wolford LM.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jul;104(1):e22-6. Epub 2007 May 7.

PMID:
17482848
26.

Molecular mimicry and horror autotoxicus: do chlamydial infections elicit autoimmunity?

Swanborg RH, Boros DL, Whittum-Hudson JA, Hudson AP.

Expert Rev Mol Med. 2006 Nov 30;8(29):1-23. Review.

PMID:
17134529
27.

Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain.

Gérard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, Balin BJ, Frey WH 2nd, Bordayo EZ, Whittum-Hudson JA, Hudson AP.

FEMS Immunol Med Microbiol. 2006 Dec;48(3):355-66. Epub 2006 Oct 18.

28.

Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype.

Dreses-Werringloer U, Gérard HC, Whittum-Hudson JA, Hudson AP.

Am J Med Sci. 2006 Oct;332(4):168-74.

PMID:
17031241
29.
30.

The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype.

Gérard HC, Wildt KL, Whittum-Hudson JA, Lai Z, Ager J, Hudson AP.

Microb Pathog. 2005 Jul-Aug;39(1-2):19-26.

PMID:
15998578
31.

Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice.

Jabs DA, Gérard HC, Wei Y, Campbell AL, Hudson AP, Akpek EK, Lee B, Prendergast RA, Whittum-Hudson JA.

Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2293-8.

PMID:
15223808
32.

Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice.

Akpek EK, Jabs DA, Gérard HC, Prendergast RA, Hudson AP, Lee B, Whittum-Hudson JA.

Invest Ophthalmol Vis Sci. 2004 Jan;45(1):185-90.

PMID:
14691172
33.

Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections.

Gérard HC, Whittum-Hudson JA, Schumacher HR, Hudson AP.

Microb Pathog. 2004 Jan;36(1):35-9.

PMID:
14643638
34.

Biomimetic design in microparticulate vaccines.

Keegan ME, Whittum-Hudson JA, Mark Saltzman W.

Biomaterials. 2003 Nov;24(24):4435-43.

PMID:
12922154
35.

Infectious agents and multiple sclerosis--are Chlamydia pneumoniae and human herpes virus 6 involved?

Swanborg RH, Whittum-Hudson JA, Hudson AP.

J Neuroimmunol. 2003 Mar;136(1-2):1-8. Review.

PMID:
12620637
36.

Pathogenesis of autoimmune lacrimal gland disease in MRL/MPJ mice.

Jabs DA, Prendergast RA, Whittum-Hudson JA.

Adv Exp Med Biol. 2002;506(Pt B):771-6. No abstract available.

PMID:
12613990
37.

Human herpesvirus 6 and Chlamydia pneumoniae as etiologic agents in multiple sclerosis - a critical review.

Swanborg RH, Whittum-Hudson JA, Hudson AP.

Microbes Infect. 2002 Nov;4(13):1327-33. Review.

PMID:
12443897
38.

Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae.

Gerard HC, Wang Z, Whittum-Hudson JA, El-Gabalawy H, Goldbach-Mansky R, Bardin T, Schumacher HR, Hudson AP.

J Rheumatol. 2002 Sep;29(9):1827-35.

PMID:
12233874
39.

Persistent Chlamydiae and chronic arthritis.

Villareal C, Whittum-Hudson JA, Hudson AP.

Arthritis Res. 2002;4(1):5-9. Epub 2001 Oct 8. Review.

40.

Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection.

Gérard HC, Freise J, Wang Z, Roberts G, Rudy D, Krauss-Opatz B, Köhler L, Zeidler H, Schumacher HR, Whittum-Hudson JA, Hudson AP.

Microbes Infect. 2002 Jan;4(1):13-22.

PMID:
11825770
41.

Vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGFbeta), and interleukin-6 (IL-6) in experimental herpesvirus retinopathy: association with inflammation and viral infection.

Vinores SA, Derevjanik NL, Shi A, Vinores MA, Klein DA, Whittum-Hudson JA.

Histol Histopathol. 2001 Oct;16(4):1061-71. doi: 10.14670/HH-16.1061.

PMID:
11642726
42.

Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice.

Jabs DA, Prendergast RA, Rorer EM, Hudson AP, Whittum-Hudson JA.

Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2567-71.

PMID:
11581200
43.

Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection.

Gérard HC, Krausse-Opatz B, Wang Z, Rudy D, Rao JP, Zeidler H, Schumacher HR, Whittum-Hudson JA, Köhler L, Hudson AP.

Mol Microbiol. 2001 Aug;41(3):731-41.

44.

A Chlamydia pneumoniae-specific peptide induces experimental autoimmune encephalomyelitis in rats.

Lenz DC, Lu L, Conant SB, Wolf NA, Gérard HC, Whittum-Hudson JA, Hudson AP, Swanborg RH.

J Immunol. 2001 Aug 1;167(3):1803-8.

45.

The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.

Whittum-Hudson JA, Rudy D, Gèrard H, Vora G, Davis E, Haller PK, Prattis SM, Hudson AP, Saltzman WM, Stuart ES.

Vaccine. 2001 Jul 16;19(28-29):4061-71.

PMID:
11427283
46.

Optimised sample DNA preparation for detection of Chlamydia trachomatis in synovial tissue by polymerase chain reaction and ligase chain reaction.

Freise J, Gérard HC, Bunke T, Whittum-Hudson JA, Zeidler H, Köhler L, Hudson AP, Kuipers JG.

Ann Rheum Dis. 2001 Feb;60(2):140-5.

47.

Chlamydia and associated arthritis.

Inman RD, Whittum-Hudson JA, Schumacher HR, Hudson AP.

Curr Opin Rheumatol. 2000 Jul;12(4):254-62. Review.

PMID:
10910176
48.

Microfibril abnormalities of the lens capsule in patients with Marfan syndrome and ectopia lentis.

Traboulsi EI, Whittum-Hudson JA, Mir SH, Maumenee IH.

Ophthalmic Genet. 2000 Mar;21(1):9-15.

PMID:
10779844
49.

Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.

Jabs DA, Lee B, Whittum-Hudson JA, Prendergast RA.

Invest Ophthalmol Vis Sci. 2000 Mar;41(3):826-31.

PMID:
10711700
50.

Rapid communication: Cervical Chlamydia trachomatis in women at low risk for infection.

Cheema MA, Rahman MU, Whittum-Hudson JA, Hudson AP.

Am J Med Sci. 2000 Feb;319(2):123-5.

PMID:
10698098

Supplemental Content

Loading ...
Support Center